Infraredx, Inc.

Infraredx, a Nipro company, is an intravascular imaging company committed to advancing the diagnosis and management of coronary artery disease around the world. We harness 30 years of research into the association between heart attacks and lipid core plaques because we believe in the promise and power of intelligent insights. Infraredx commands a bold vision, pioneering the design, manufacture, and distribution of technologies that address the needs of practitioners and improve outcomes for patients with coronary artery disease. With ongoing investment in several landmark global clinical trials, we are dedicated to advancing this important field of research and conducting landmark clinical trials to transform how we view, treat, and prevent heart disease.